Innovex International (INVX) Stock Slides After Q3 Earnings Margin Gains

Innovex International investors woke up to a jolt. The stock dropped 6.3% to about $28 after the Q3 2026 earnings hit the tape, even as the company reported roughly $265 million in revenue and net income of about $26 million. On a one-day chart, that looks rough. On a multi-year view, that same report feeds into a capital-light model, rising gross and adjusted EBITDA margins, and a valuation that already prices Innovex at a steep discount to some detailed cash flow estimates.

Love Innovex International's rising margins and capital-light setup but concerned the market is still treating it like a discounted outlier after this drop? Line it up against a curated group of quality undervalued stocks with stronger market support using our 29 high quality undervalued stocks.

Q3 2026 Earnings Summary

• Revenue (Q3 2026 vs. Q3 2025): US$265.1 million vs. US$240.0 million (up about 10%)
• Net Income, excluding extra items (Q3 2026 vs. Q3 2025): US$26.3 million vs. US$39.2 million (down about 33%)
• Basic EPS (Q3 2026 vs. Q3 2025): US$0.38 vs. US$0.57 (declined about 34%)
• Adjusted EBITDA Margin (Q3 2026 vs. Q3 2025): 21% vs. 18% (improved by about 3 percentage points)

Tired of scrolling through earnings tables and dense commentary trying to piece Innovex International together in your head? Get the full visual story in one place by reviewing an interactive breakdown of valuation, margins and broader financial trends inside the company report for Innovex International.

Evaluating Innovex’s Execution Against Its Bull Case

The bullish story around Innovex International leans heavily on operational fine tuning, not just more barrels drilled.

"Ongoing manufacturing consolidation, including the exit from the Eldridge facility and improved throughput in Subsea plants, is already contributing to better absorption and operating leverage, which can support gross margin and adjusted EBITDA margin stability even with mixed volumes."

Q3 results give that claim real traction. Gross margin moved to 36% and adjusted EBITDA margin reached 21%, up from 18% a year earlier. Capital expenditure remained at about 2.4% of revenue. Subsea backlog growth and free cash flow of US$32m suggest the consolidation plan is translating into leaner, higher quality earnings for Innovex International.

One Narrative has put a figure on that disagreement. → See the Narrative with its higher Fair Value, assumptions and all.

Innovex Bear Case: Project, Legal And Logistics Risks Under Review

The key concern for Innovex International is that offshore lumpiness, logistics friction and legal drag will keep free cash flow and margin progress in check, even when revenue figures look solid.

"Although the balance sheet carries about US$201 million of cash and no bank debt, giving room for further M&A and shareholder returns, the recent US$49 million legal accrual and potential for higher logistics costs in regions such as the Middle East may divert cash toward non operating items."

Q3 cash of about US$189 million and US$32 million of free cash flow indicate that liquidity is intact. Yet management flagged higher Middle East freight as a Q4 drag and the legal accrual remains unresolved, so the concern about cash diversion persists. The 6.3% share price drop suggests that investors are treating these as current issues.

Find New Setups Beyond This Quarter

Innovex International highlights that earnings momentum and share price reactions may diverge for extended periods. The real opportunity is identifying stocks that could be undervalued before the market reassesses their potential.

• Company 1 - 22% below our estimate - leans into hyperscale data center buildouts as backlog grows and operating cash generation supports expansion despite concentrated exposure and elevated working capital needs.
• Company 2 - 31% below our estimate - embeds itself in digital infrastructure by supplying chips and software that keep data-heavy workloads processed, connected, and secured across diverse computing architectures.
• Company 3 - 48% below our estimate - shifts from low-margin assembly to co-designing complex hardware so customers integrate its engineering into medical devices, autonomous systems, and industrial automation projects.

Three companies from the same screener. Open every one of the 29 undervalued companies on it →

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com